Center for the Study of Aphasia Recovery (C-STAR)
失语症康复研究中心 (C-STAR)
基本信息
- 批准号:9083041
- 负责人:
- 金额:$ 229.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-01 至 2021-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdultAffectAgeAmericanAnatomyAphasiaAreaBehaviorBehavior TherapyBehavioralBrainBrain InjuriesCenters for Disease Control and Prevention (U.S.)CerebrumChronicClinicalCognitiveCollaborationsCollectionCommunicationConsultDataData CollectionData SetDiagnosisDoctor of PhilosophyDorsalEducationElderlyElectric StimulationElectrical Stimulation of the BrainEmploymentEmployment OpportunitiesFamilyFriendsGoalsImpairmentIndividualLanguageLanguage DisordersLeadLeftLesionLifeLife ExpectancyLinguisticsLiteratureLocationMachine LearningMagnetic Resonance ImagingMeasuresMeta-AnalysisModelingNeuroanatomyOutcomePatientsPerformancePerfusionPhasePrevalenceProceduresProcessPrognostic MarkerPublic HealthQualifyingQuality of lifeRecoveryResearchResearch PersonnelResearch Project GrantsResidual stateResourcesSelective Serotonin Reuptake InhibitorSemanticsSeveritiesSocial isolationSouth CarolinaSpeechStagingStreamStrokeStructureTestingTimeTranslationsTreatment EffectivenessTreatment outcomeUnited StatesWorkacute strokeaphasia recoveryaphasicbehavior testchronic strokeclinical practicecostdisabilityexperiencefitnesshemisphere damageimprovedimproved outcomeindividual patientlanguage impairmentlanguage processingmortalityneuroimagingneurophysiologyoutcome forecastphonologypredicting responsepredictive modelingpreventpublic health relevanceresponsespeech processingstroke survivorsuccesstheoriestreatment responsewasting
项目摘要
DESCRIPTION (Description as provided by applicant): Stroke is the leading cause of adult disability in the United States, making it a major public health concern (1). The Centers for Disease Control (CDC) estimates the annual cost of stroke in the United States to be $36.5 billion (1). Accordingly, it is clear that the negative personal and societal impact of stroke is vry high. Stroke is typically thought to affect older persons; however, many younger individuals also suffer strokes. For example, at least half of all stroke patients in the state of South Carolina ar under the age of 60 (2). Approximately a quarter of all chronic stroke survivors present with aphasia, a language disorder caused by damage to the speech and language areas of the brain (3, 4). The prevalence of chronic aphasia in the United States is estimated to be one million. Aphasia can vary in severity from very profound impairment that renders patients mute and without the ability to understand others' speech, to milder forms where patients have great difficulty retrieving specific words. In the chronic stage of stroke, aphasia has been identified a the strongest predictor of poor quality of life. Aphasia not only influences the ability to communicate with family and friends, but also drastically decreases education and employment opportunities. Although some degree of spontaneous recovery from aphasia is typical in the first weeks and months following stroke, many patients are left with devastating communication problems. Once aphasia has become a chronic condition, the only road to recovery is through aphasia therapy. Several meta-analysis studies suggest that aphasia therapy is effective. In spite of decades of research, very little is known about which patients benefit the most from treatment and what kind of treatment should be administered to patients with different impairment profiles. The overarching goal of the research proposed here is to improve aphasia treatment effectiveness as well as identify patient factors that can be used to improve diagnosis of language impairment, guide aphasia treatment, and predict prognosis. Specifically, the focus of our center (Center for the Study of Aphasia Recovery; C-STAR) is to examine the extent to which factors such as behavioral aphasia treatment, electrical brain stimulation, and residual brain function influence aphasia recovery. To accomplish our research goals, this project will rely on collaboration among four main investigators: Drs. Julius Fridriksson, Argye Hillis, Chris Rorden, and Greg Hickok. Projects led by Fridriksson (chronic patients) and Hillis (acute patients) will focus on factors that may promote improved outcome of aphasia therapy. Both projects will yield a vast, unique dataset including measures of brain status and response to aphasia treatment. Relying on this dataset, Rorden's project will predict recovery from aphasia using machine learning approaches whereas Hickok will utilize the same data to better understand aphasic impairment in relation to contemporary models of speech and language processing.
描述(描述由适用的描述):中风是美国成人残疾的主要原因,使其成为主要的公共卫生问题(1)。疾病控制中心(CDC)估计,美国中风的年成本为365亿美元(1)。根据以下内容,很明显,中风的负面影响和社会影响很高。通常认为中风会影响老年人。但是,许多年轻人也遭受中风。例如,在60岁以下的南卡罗来纳州AR州至少一半的中风患者中,至少有一半(2)。大约四分之一的慢性中风存活中出现失语症,这种语言障碍是由于对大脑的言语和语言区域的损害引起的(3,4)。据估计,美国慢性失语症的流行率为一百万。失语症的严重性可能会因非常严重的障碍而变化,从而使患者静音并且没有理解他人言语的能力,到患者很难检索特定单词的米勒形式。在中风的慢性阶段,失语症已被确定为生活质量差的有力预测指标。失语症不仅会影响与家人和朋友交流的能力,而且会大大减少教育和就业机会。尽管在中风后的头几周和几个月中,从失语症中恢复了一定程度的赞助,但许多患者遭受了毁灭性的沟通问题。一旦失语症已成为慢性病,康复的唯一道路就是通过失语治疗。几项荟萃分析研究表明,失语症治疗是有效的。尽管有数十年的研究,但对哪些患者从治疗中受益最大,以及应对不同损伤谱的患者进行哪种治疗的了解很少。这里提出的研究的总体目标是提高失语症治疗效果,并确定可用于改善语言障碍诊断,指导失语症治疗和预测性预后的患者因素。具体而言,我们中心(失语症恢复研究中心; C-Star)的重点是检查行为失语症治疗,电脑刺激和残留脑功能等因素的程度。为了实现我们的研究目标,该项目将依靠四个主要研究人员之间的协作:DRS。朱利叶斯·弗里德里克森(Julius Fridriksson),阿吉·希利斯(Argye Hillis),克里斯·罗登(Chris Rorden)和格雷格·希科克(Greg Hickok)。弗里德里克森(慢性患者)和希尔斯(急性患者)领导的项目将重点关注可能促进失语症治疗结果的因素。这两个项目都将产生一个庞大的独特数据集,包括大脑状况的措施和对失语症治疗的反应。依靠该数据集,Rorden的项目将使用机器学习方法预测失语症的恢复,而Hickok将利用相同的数据来更好地了解与当代语音和语言处理模型有关的失语性障碍。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JULIUS FRIDRIKSSON其他文献
JULIUS FRIDRIKSSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JULIUS FRIDRIKSSON', 18)}}的其他基金
Center for the Study of Aphasia Recovery (C-STAR)
失语症康复研究中心 (C-STAR)
- 批准号:
10672777 - 财政年份:2016
- 资助金额:
$ 229.16万 - 项目类别:
Center for the Study of Aphasia Recovery (C-STAR)
失语症康复研究中心 (C-STAR)
- 批准号:
10617705 - 财政年份:2016
- 资助金额:
$ 229.16万 - 项目类别:
Center for the Study of Aphasia Recovery (C-STAR)
失语症康复研究中心 (C-STAR)
- 批准号:
10390284 - 财政年份:2016
- 资助金额:
$ 229.16万 - 项目类别:
Center for the Study of Aphasia Recovery (C-STAR)
失语症康复研究中心 (C-STAR)
- 批准号:
9889924 - 财政年份:2016
- 资助金额:
$ 229.16万 - 项目类别:
Improving usage of the Aphasia Research Cohort (ARC) repository
改善失语症研究队列 (ARC) 存储库的使用
- 批准号:
10786684 - 财政年份:2016
- 资助金额:
$ 229.16万 - 项目类别:
相似国自然基金
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
儿童期受虐经历影响成年人群幸福感:行为、神经机制与干预研究
- 批准号:32371121
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:32200888
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
生活方式及遗传背景对成人不同生命阶段寿命及死亡的影响及机制的队列研究
- 批准号:82173590
- 批准年份:2021
- 资助金额:56.00 万元
- 项目类别:面上项目
相似海外基金
Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
- 批准号:
10822202 - 财政年份:2024
- 资助金额:
$ 229.16万 - 项目类别:
A rigorous test of dual process model predictions for problematic alcohol involvement
对有问题的酒精参与的双过程模型预测的严格测试
- 批准号:
10679252 - 财政年份:2023
- 资助金额:
$ 229.16万 - 项目类别:
The Role of Dopamine in Cognitive Resilience to Alzheimer's Disease Pathology in Healthy Older Adults
多巴胺在健康老年人阿尔茨海默氏病病理认知弹性中的作用
- 批准号:
10678125 - 财政年份:2023
- 资助金额:
$ 229.16万 - 项目类别:
Prevention of intracellular infection in diabetic wounds by commensal Staphylococcus epidermidis
共生表皮葡萄球菌预防糖尿病伤口细胞内感染
- 批准号:
10679628 - 财政年份:2023
- 资助金额:
$ 229.16万 - 项目类别: